Table 1. Participant characteristics.
| Placebo | Curcumin | |||
|---|---|---|---|---|
| Week 0 | Week 12 | Week 0 | Week 12 | |
| N, men/women | 11/8 | – | 10/10 | – |
| Age, years | 61±2 | – | 63±2 | – |
| Body mass, kg | 76±3* | 75±3 | 68±2 | 68±3 |
| Body mass index, kg/m2 | 25±1 | 25±1 | 24±1 | 24±1 |
| Waist to hip ratio, UL | 0.81±0.05 | 0.85±0.02 | 0.84±0.02 | 0.84±0.02 |
| Body fat, % | 27.9±2.0 | 27.8±2.0 | 30.1±1.9 | 30.2±1.9 |
| Systolic blood pressure, mmHg | 120±3 | 122±3 | 121±3 | 121±3 |
| Diastolic blood pressure, mmHg | 73±2 | 73±1 | 72±1 | 71±1 |
| Resting heart rate, beats/minL | 56±2 | 55±2 | 55±1 | 57±2 |
| VO2 max, mL/kg/min | 33±1 | 33±1 | 31±1 | 31±1 |
| Physical activity energy expenditure, kcal/wkL | 6095±872 | 5334±819 | 5720±954 | 5416±984 |
| Total cholesterol, mg/dL | 177±6 | 173±6 | 175±8 | 174±6 |
| HDL-cholesterol, mg/dLL | 56±4 | 52±4 | 55±5 | 56±4 |
| LDL-cholesterol, mg/dL | 103±6 | 102±6 | 103±7 | 101±6 |
| Triglycerides, mg/dLL | 97±15 | 93±15 | 86±11 | 91±12 |
| Glucose, mg/dL | 84±2 | 85±2 | 85±2 | 87±2 |
| C-reactive protein, mg/LL | 0.96±0.26 | 1.15±0.34 | 0.81±0.14 | 0.72±0.12 |
Data are mean±SE; HDL, high-density lipoprotein; LDL, low-density lipoprotein;
L
Data log transformed for statistical analysis;
*
P=0.03 vs. curcumin week 0